Overview

Amobarbital and Cardiopulmonary Bypass

Status:
RECRUITING
Trial end date:
2026-03-01
Target enrollment:
Participant gender:
Summary
Explore the effects of amobarbital on myocardial protection and prognosis in patients undergoing cardiac surgery with cardiopulmonary bypass, investigate the new usage of old drugs, and provide reliable clinical scientific basis for its potential value in better clinical treatment.
Phase:
NA
Details
Lead Sponsor:
Tongji Hospital
Treatments:
Amobarbital
Midazolam